Intercept Pharmaceuticals Inc Valor contable por acción
¿Qué es el Valor contable por acción de Intercept Pharmaceuticals Inc?
El Valor contable por acción de Intercept Pharmaceuticals Inc es 3.84
¿Cuál es la definición de Valor contable por acción?
El valor en libros por acción es el activo de una empresa menos el pasivo dividido por el número de acciones en circulación.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor contable por acción de compañías en Sector Health Care en NASDAQ en comparadas con Intercept Pharmaceuticals Inc
¿Qué hace Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Empresas con valor contable por acción similar a Intercept Pharmaceuticals Inc
- Linus Digital Finance Ag tiene Valor contable por acción de 3.83
- Xinyi Glass tiene Valor contable por acción de 3.83
- Himax Technologies tiene Valor contable por acción de 3.83
- Bhandari Hosiery Exports tiene Valor contable por acción de 3.83
- Fast Retailing Co tiene Valor contable por acción de 3.84
- SmarTone Telecommunications tiene Valor contable por acción de 3.84
- Intercept Pharmaceuticals Inc tiene Valor contable por acción de 3.84
- Eisai Co tiene Valor contable por acción de 3.84
- Extended Stay America Inc tiene Valor contable por acción de 3.84
- Nufarm tiene Valor contable por acción de 3.84
- Birchcliff tiene Valor contable por acción de 3.84
- Extended Stay America tiene Valor contable por acción de 3.84
- MMG tiene Valor contable por acción de 3.84